Plant-derived vaccines against diarrheal diseases (Q36056011)

11 August 2017

1 reference

title

Plant-derived vaccines against diarrheal diseases (English)

1 reference

11 August 2017

Carol O Tacket

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

15

1 reference

11 August 2017

page(s)

1866-1869

1 reference

Transgenic plants as protein factories

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Transgenic plants as factories for biopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Producing proteins in transgenic plants and animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Corn as a production system for human and animal vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Transgenic plants as vaccine production systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Plant-based vaccines: unique advantages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Maize (Zea mays)-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Delivery of subunit vaccines in maize seed.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Efficacy of a food plant-based oral cholera toxin B subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Expression of cholera toxin B subunit oligomers in transgenic potato plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Norwalk virus genome cloning and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Identification of patatin as a novel allergen for children with positive skin prick test responses to raw potato

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

Food plant-delivered cholera toxin B subunit for vaccination and immunotolerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.019

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.019

1 reference

11 August 2017

1 reference